Publication

Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland

Related publications (35)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland

Graph Chatbot

Chat with Graph Search

Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection

Virtual reality intervention alleviates dyspnoea in patients recovering from COVID-19 pneumonia

Optimized numerical solutions of SIRDVW multiage model controlling SARS-CoV-2 vaccine roll out: An application to the Italian scenario

Secondary Structures of MERS-CoV, SARS-CoV, and SARS-CoV-2 Spike Proteins Revealed by Infrared Vibrational Spectroscopy

Cryo-EM structures and binding of mouse and human ACE2 to SARS-CoV-2 variants of concern indicate that mutations enabling immune escape could expand host range

Impact of COVID-19 on long-term lung function in lung transplant recipients: A single-center retrospective cohort study

Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland

Host genomics of SARS-CoV-2 infection

Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma

Point-of-care lung ultrasonography for early identification of mild COVID-19: a prospective cohort of outpatients in a Swiss screening center